205 related articles for article (PubMed ID: 36333526)
21. Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion.
Lee DY; Kim Y; Park JS; Choi JU; Jeong HG; Park CH
Anticancer Res; 2023 Sep; 43(9):3897-3904. PubMed ID: 37648291
[TBL] [Abstract][Full Text] [Related]
22. The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their
Heinze A; Grebe B; Bremm M; Huenecke S; Munir TA; Graafen L; Frueh JT; Merker M; Rettinger E; Soerensen J; Klingebiel T; Bader P; Ullrich E; Cappel C
Front Immunol; 2019; 10():2816. PubMed ID: 31849984
[TBL] [Abstract][Full Text] [Related]
23. Development of an antibody-ligand fusion protein scFvCD16A
Li Y; Xie S; Chen M; Li H; Wang Y; Fan Y; An K; Wu Y; Xiao W
Microb Cell Fact; 2023 Apr; 22(1):67. PubMed ID: 37041591
[TBL] [Abstract][Full Text] [Related]
24. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
[TBL] [Abstract][Full Text] [Related]
25. Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy.
Granzin M; Soltenborn S; Müller S; Kollet J; Berg M; Cerwenka A; Childs RW; Huppert V
Cytotherapy; 2015 May; 17(5):621-32. PubMed ID: 25881519
[TBL] [Abstract][Full Text] [Related]
26. Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells.
Denman CJ; Senyukov VV; Somanchi SS; Phatarpekar PV; Kopp LM; Johnson JL; Singh H; Hurton L; Maiti SN; Huls MH; Champlin RE; Cooper LJ; Lee DA
PLoS One; 2012; 7(1):e30264. PubMed ID: 22279576
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies.
Suck G; Oei VY; Linn YC; Ho SH; Chu S; Choong A; Niam M; Koh MB
Exp Hematol; 2011 Sep; 39(9):904-14. PubMed ID: 21703984
[TBL] [Abstract][Full Text] [Related]
28. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment.
Oyer JL; Pandey V; Igarashi RY; Somanchi SS; Zakari A; Solh M; Lee DA; Altomare DA; Copik AJ
Cytotherapy; 2016 May; 18(5):653-63. PubMed ID: 27059202
[TBL] [Abstract][Full Text] [Related]
30. Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function.
Zhang C; Kadu S; Xiao Y; Johnson O; Kelly A; O'Connor RS; Lai M; Kong H; Srivatsa S; Tai V; Greenblatt E; Holmes M; Riley JL; June CH; Sheppard NC
Cancer Immunol Res; 2023 Nov; 11(11):1524-1537. PubMed ID: 37649085
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15.
Gong W; Xiao W; Hu M; Weng X; Qian L; Pan X; Ji M
Tissue Antigens; 2010 Dec; 76(6):467-75. PubMed ID: 20670353
[TBL] [Abstract][Full Text] [Related]
32. [Expansion of human natural killer cells ex vivo].
Huang QS; Li Q; Huang Y; Shang P; Zhang MJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1167-9. PubMed ID: 19068202
[TBL] [Abstract][Full Text] [Related]
33. Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers.
Kim EK; Ahn YO; Kim S; Kim TM; Keam B; Heo DS
Cytotherapy; 2013 Feb; 15(2):231-241.e1. PubMed ID: 23321334
[TBL] [Abstract][Full Text] [Related]
34. Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate.
Johnson CDL; Zale NE; Frary ED; Lomakin JA
Front Immunol; 2022; 13():803380. PubMed ID: 35320938
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.
Lim SA; Kim TJ; Lee JE; Sonn CH; Kim K; Kim J; Choi JG; Choi IK; Yun CO; Kim JH; Yee C; Kumar V; Lee KM
Cancer Res; 2013 Apr; 73(8):2598-607. PubMed ID: 23580577
[TBL] [Abstract][Full Text] [Related]
36. Cellular therapy: Adoptive immunotherapy with expanded natural killer cells.
Lee DA
Immunol Rev; 2019 Jul; 290(1):85-99. PubMed ID: 31355489
[TBL] [Abstract][Full Text] [Related]
37. Improving natural killer cell cancer immunotherapy.
Berrien-Elliott MM; Romee R; Fehniger TA
Curr Opin Organ Transplant; 2015 Dec; 20(6):671-80. PubMed ID: 26414502
[TBL] [Abstract][Full Text] [Related]
38. Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy.
Lapteva N; Parihar R; Rollins LA; Gee AP; Rooney CM
Methods Mol Biol; 2016; 1441():195-202. PubMed ID: 27177667
[TBL] [Abstract][Full Text] [Related]
39. Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies.
Demel I; Koristek Z; Motais B; Hajek R; Jelinek T
Am J Hematol; 2022 Jun; 97(6):802-817. PubMed ID: 35285978
[TBL] [Abstract][Full Text] [Related]
40. Autologous Immune Enhancement Therapy for Cancer - Our experience since 2004.
Terunuma H
J Stem Cells Regen Med; 2012; 8(3):205-6. PubMed ID: 24693200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]